Table 2 Clinical outcomes (primary and secondary) of the study population
Diaphragmatic function | |||||
|---|---|---|---|---|---|
Outcome | Overall | DD+ | DD− | Relative risk | p Value |
NIV failure | 26 (35%) | 18 (75%) | 8 (16%) | 4.4 (2.3–8.7) | < 0.0001 |
RICU mortality | 16 (21%) | 10 (42%) | 6 (12%) | 3.1 (1.3–7.7) | 0.007 |
In-hospital mortality | 19 (25%) | 11 (46%) | 8 (16%) | 2.7 (1.3–5.7) | 0.02 |
90-day mortality | 29 (39%) | 14 (58%) | 15 (29%) | 1.8 (1.1–3.1) | 0.04 |
Tracheostomy | 7 (9%) | 5 (21%) | 2 (3.9%) | 5 (1.2–21) | 0.04 |
MV duration, days | 10 (3–11) | 16 (5.5–18.8) | 8 (2–9) | 2 (1.4–3.3) | 0.03 |
ICU stay, days | 14 (6–17) | 17 (8–21) | 12 (7–16) | 2.8 (1.5–4.2) | 0.012 |
Hospital stay, days | 21 (10–23) | 21 (10–23) | 22 (10–24) | 1.1 (0.5–1.3) | n.s. (0.9) |